drugset / Trial / NCT01781234

Efficacy Study of Intranasal Insulin to Treat Tobacco Abstinence Syndrome

NCT01781234

Phase 2 Completed 51 enrolled Ajna Hamidovic
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate safety and efficacy of intranasal insulin in abstinent smokers. Groups' (placebo vs. insulin) cognitive function and stress response will be compared.

Timeline

Start
2013-08
Primary completion
2016-05
Completion
2016-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic Intranasal